Johnson & Johnson SEC filings JNJ

Johnson & Johnson has 1,000 filings in SEC EDGAR's recent list, going back to Aug 2, 2018. Its latest annual report, Form ARS, was filed on Mar 11, 2026 for the period ended Dec 28, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 21, 2026, covering the quarter ended Sep 27, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (results of operations). The company's fiscal year ends on January 3.

Johnson & Johnson SEC filings
Form Description Filed Period
13F-HR Filing Oct 26, 2026 Sep 30, 2026
10-Q Quarterly report Oct 21, 2026 Sep 27, 2026
8-K Current report
Results of operations
Oct 13, 2026 Oct 13, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
4 Insider transaction Sep 4, 2026 Sep 2, 2026
144 Notice of proposed sale Sep 2, 2026 —
3 Initial insider ownership Sep 1, 2026 Sep 1, 2026
4 Insider transaction Aug 18, 2026 Aug 17, 2026
144 Notice of proposed sale Aug 17, 2026 —
4 Insider transaction Aug 14, 2026 Aug 13, 2026
144 Notice of proposed sale Aug 13, 2026 —
N-PX Filing Aug 11, 2026 Jun 30, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
4 Insider transaction Aug 7, 2026 Aug 6, 2026
144 Notice of proposed sale Aug 6, 2026 —
13F-HR Filing Aug 6, 2026 Jun 30, 2026
144 Notice of proposed sale Aug 5, 2026 —
8-K Current report
Officer or director change
Aug 4, 2026 Aug 4, 2026
8-K Current report
Regulation FD disclosure
Jul 29, 2026 Jul 29, 2026
8-K Current report
Regulation FD disclosure
Jul 28, 2026 Jul 27, 2026
10-Q Quarterly report Jul 23, 2026 Jun 28, 2026
4 Insider transaction Jul 21, 2026 Jul 20, 2026
144 Notice of proposed sale Jul 20, 2026 —
8-K Current report
Results of operations
Jul 15, 2026 Jul 15, 2026
11-K Employee savings plan report Jun 25, 2026 Dec 31, 2025
11-K Employee savings plan report Jun 25, 2026 Dec 31, 2025
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
144 Notice of proposed sale Jun 11, 2026 —
SD Specialized disclosure (conflict minerals) May 27, 2026 —
13F-HR Filing May 13, 2026 Mar 31, 2026
4 Insider transaction May 4, 2026 May 1, 2026
SCHEDULE 13G Ownership over 5% (passive) May 1, 2026 —
8-K Current report
Shareholder vote results
Apr 28, 2026 Apr 23, 2026
4 Insider transaction Apr 27, 2026 Apr 23, 2026
4 Insider transaction Apr 27, 2026 Apr 23, 2026
4 Insider transaction Apr 27, 2026 Apr 23, 2026
4 Insider transaction Apr 27, 2026 Apr 23, 2026
4 Insider transaction Apr 27, 2026 Apr 23, 2026
4 Insider transaction Apr 27, 2026 Apr 23, 2026
4 Insider transaction Apr 27, 2026 Apr 23, 2026
4 Insider transaction Apr 27, 2026 Apr 23, 2026
4 Insider transaction Apr 27, 2026 Apr 23, 2026
4 Insider transaction Apr 27, 2026 Apr 23, 2026
4 Insider transaction Apr 27, 2026 Apr 23, 2026
10-Q Quarterly report Apr 22, 2026 Mar 29, 2026
8-K Current report
Results of operations, Other events
Apr 14, 2026 Apr 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
13F-HR/A Filing Mar 18, 2026 Dec 31, 2025
13F-HR/A Filing Mar 18, 2026 Sep 30, 2025
4 Insider transaction Mar 12, 2026 Mar 4, 2025
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
ARS Annual report to shareholders Mar 11, 2026 Dec 28, 2025
DEFA14A Additional proxy material Mar 11, 2026 —
DEF 14A Proxy statement Mar 11, 2026 Mar 11, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
144 Notice of proposed sale Feb 27, 2026 —
4 Insider transaction Feb 23, 2026 Feb 20, 2026
144 Notice of proposed sale Feb 20, 2026 —
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 15, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
13F-HR Filing Feb 13, 2026 Dec 31, 2025
144 Notice of proposed sale Feb 13, 2026 —
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
S-3ASR Automatic shelf registration Feb 11, 2026 —
10-K Annual report Feb 11, 2026 Dec 28, 2025
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 9, 2026 Feb 6, 2026
4 Insider transaction Feb 9, 2026 Feb 6, 2026
4 Insider transaction Feb 6, 2026 Feb 5, 2026
144 Notice of proposed sale Feb 5, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2026 —
5 Annual insider ownership Jan 28, 2026 Aug 23, 2023
4 Insider transaction Jan 28, 2026 Jan 26, 2026
144 Notice of proposed sale Jan 26, 2026 —
8-K Current report
Results of operations
Jan 21, 2026 Jan 21, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 12, 2026 —
4/A Filing Jan 8, 2026 Nov 25, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
4 Insider transaction Dec 1, 2025 Nov 26, 2025
4 Insider transaction Dec 1, 2025 Nov 26, 2025
4 Insider transaction Nov 25, 2025 Nov 21, 2025
4 Insider transaction Nov 14, 2025 Nov 12, 2025
13F-HR Filing Nov 13, 2025 Sep 30, 2025
4 Insider transaction Nov 10, 2025 Nov 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 22, 2025 —
10-Q Quarterly report Oct 22, 2025 Sep 28, 2025
4 Insider transaction Oct 20, 2025 Oct 17, 2025
144 Notice of proposed sale Oct 17, 2025 —
8-K Current report
Results of operations, Other events
Oct 14, 2025 Oct 14, 2025
3 Initial insider ownership Sep 15, 2025 Sep 8, 2025
4 Insider transaction Sep 11, 2025 Sep 9, 2025
4 Insider transaction Sep 11, 2025 Sep 9, 2025
4 Insider transaction Sep 11, 2025 Sep 9, 2025
8-K Current report
Officer or director change
Sep 9, 2025 Sep 8, 2025
4 Insider transaction Sep 5, 2025 Sep 4, 2025
144 Notice of proposed sale Sep 4, 2025 —
4 Insider transaction Sep 3, 2025 Aug 29, 2025
144 Notice of proposed sale Aug 29, 2025 —
N-PX Filing Aug 26, 2025 Jun 30, 2025
4 Insider transaction Aug 25, 2025 Aug 22, 2025
144 Notice of proposed sale Aug 22, 2025 —
4 Insider transaction Aug 18, 2025 Aug 15, 2025
144 Notice of proposed sale Aug 15, 2025 —
10-Q Quarterly report Jul 24, 2025 Jun 29, 2025
13F-HR Filing Jul 22, 2025 Jun 30, 2025
4 Insider transaction Jul 18, 2025 Jul 17, 2025
144 Notice of proposed sale Jul 17, 2025 —
8-K Current report
Results of operations
Jul 16, 2025 Jul 16, 2025
3 Initial insider ownership Jul 8, 2025 Jul 1, 2025
11-K Employee savings plan report Jun 24, 2025 Dec 31, 2024
11-K Employee savings plan report Jun 24, 2025 Dec 31, 2024
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
8-K Current report
Officer or director change
Jun 10, 2025 Jun 10, 2025
SD Specialized disclosure (conflict minerals) May 28, 2025 —
13F-HR Filing May 7, 2025 Mar 31, 2025
4 Insider transaction May 5, 2025 May 1, 2025
UPLOAD Letter from the SEC May 2, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Apr 30, 2025 Apr 24, 2025
4 Insider transaction Apr 28, 2025 Apr 24, 2025
4 Insider transaction Apr 28, 2025 Apr 24, 2025
4 Insider transaction Apr 28, 2025 Apr 24, 2025
4 Insider transaction Apr 28, 2025 Apr 24, 2025
4 Insider transaction Apr 28, 2025 Apr 24, 2025
4 Insider transaction Apr 28, 2025 Apr 24, 2025
4 Insider transaction Apr 28, 2025 Apr 24, 2025
4 Insider transaction Apr 28, 2025 Apr 24, 2025
4 Insider transaction Apr 28, 2025 Apr 24, 2025
10-Q Quarterly report Apr 23, 2025 Mar 30, 2025
CORRESP Letter to the SEC Apr 23, 2025 —
PX14A6G Bowyer research - px14a6g Apr 23, 2025 —
UPLOAD Letter from the SEC Apr 16, 2025 —
8-K Current report
Results of operations, Other events
Apr 15, 2025 Apr 15, 2025
8-K Current report
Regulation FD disclosure
Apr 3, 2025 Mar 31, 2025
PX14A6G Filing Mar 20, 2025 —
4 Insider transaction Mar 19, 2025 Mar 18, 2025
DEFA14A Additional proxy material Mar 12, 2025 —
ARS Annual report to shareholders Mar 12, 2025 Dec 29, 2024
DEF 14A Proxy statement Mar 12, 2025 Mar 12, 2025
DFAN14A Filing Mar 7, 2025 —
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
5 Annual insider ownership Feb 28, 2025 Dec 31, 2024
CERT Nyse certification Feb 28, 2025 —
4 Insider transaction Feb 26, 2025 Feb 25, 2025
8-A12B Filing Feb 26, 2025 —
8-K Current report
Other events
Feb 26, 2025 Feb 26, 2025
DFAN14A Filing Feb 25, 2025 —
144 Notice of proposed sale Feb 25, 2025 —
424B2 Prospectus Feb 21, 2025 —
8-K Current report
Other events
Feb 20, 2025 Feb 20, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
424B2 Prospectus Feb 19, 2025 —
FWP Free writing prospectus Feb 19, 2025 —
424B5 Prospectus supplement Feb 19, 2025 —
4 Insider transaction Feb 18, 2025 Feb 14, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
JNJ (NYSE)
Fiscal year ends
January 3
Incorporated in
NJ
Headquarters
New Brunswick, NJ
SEC filer status
Large accelerated filer
SEC CIK
200406
Former names
JOHNSON & JOHNSON ET AL (until Jan 23, 1996)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.